• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

溴结构域-乙酰赖氨酸相互作用小分子抑制剂的开发与应用进展。

Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.

机构信息

Chemistry Research Laboratory, Department of Chemistry, University of Oxford, Mansfield Road, Oxford, OX1 3TA, U.K.

出版信息

J Med Chem. 2012 Nov 26;55(22):9393-413. doi: 10.1021/jm300915b. Epub 2012 Sep 27.

DOI:10.1021/jm300915b
PMID:22924434
Abstract

Bromodomains, protein modules that recognize and bind to acetylated lysine, are emerging as important components of cellular machinery. These acetyl-lysine (KAc) "reader" domains are part of the write-read-erase concept that has been linked with the transfer of epigenetic information. By reading KAc marks on histones, bromodomains mediate protein-protein interactions between a diverse array of partners. There has been intense activity in developing potent and selective small molecule probes that disrupt the interaction between a given bromodomain and KAc. Rapid success has been achieved with the BET family of bromodomains, and a number of potent and selective probes have been reported. These compounds have enabled linking of the BET bromodomains with diseases, including cancer and inflammation, suggesting that bromodomains are druggable targets. Herein, we review the biology of the bromodomains and discuss the SAR for the existing small molecule probes. The biology that has been enabled by these compounds is summarized.

摘要

溴结构域是一种能够识别和结合乙酰化赖氨酸的蛋白模块,它正在成为细胞机制中的重要组成部分。这些乙酰化赖氨酸(KAc)“读取器”结构域是与表观遗传信息传递相关的“写入-读取-擦除”概念的一部分。通过读取组蛋白上的 KAc 标记,溴结构域介导了各种不同的伙伴之间的蛋白质-蛋白质相互作用。目前,开发能够有效且选择性地破坏特定溴结构域与 KAc 之间相互作用的小分子探针的活动非常活跃。BET 家族的溴结构域已经取得了快速的成功,并且已经报道了许多有效且选择性的探针。这些化合物使得 BET 溴结构域与癌症和炎症等疾病联系起来,这表明溴结构域是可成药的靶标。本文综述了溴结构域的生物学特性,并讨论了现有小分子探针的 SAR。总结了这些化合物所带来的生物学意义。

相似文献

1
Progress in the development and application of small molecule inhibitors of bromodomain-acetyl-lysine interactions.溴结构域-乙酰赖氨酸相互作用小分子抑制剂的开发与应用进展。
J Med Chem. 2012 Nov 26;55(22):9393-413. doi: 10.1021/jm300915b. Epub 2012 Sep 27.
2
Small molecule inhibitors of bromodomain-acetyl-lysine interactions.溴结构域-乙酰赖氨酸相互作用的小分子抑制剂
ACS Chem Biol. 2015 Jan 16;10(1):22-39. doi: 10.1021/cb500996u.
3
Bromodomains as therapeutic targets.溴结构域作为治疗靶点。
Expert Rev Mol Med. 2011 Sep 13;13:e29. doi: 10.1017/S1462399411001992.
4
Metabolically Derived Lysine Acylations and Neighboring Modifications Tune the Binding of the BET Bromodomains to Histone H4.代谢衍生的赖氨酸酰化及其邻近修饰调节BET溴结构域与组蛋白H4的结合。
Biochemistry. 2017 Oct 17;56(41):5485-5495. doi: 10.1021/acs.biochem.7b00595. Epub 2017 Oct 5.
5
Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors.破坏乙酰赖氨酸识别:溴结构域抑制剂的开发进展
J Med Chem. 2016 Feb 25;59(4):1271-98. doi: 10.1021/acs.jmedchem.5b01514. Epub 2015 Dec 1.
6
The bromodomain: from epigenome reader to druggable target.溴结构域:从表观基因组读取器到可成药靶点。
Biochim Biophys Acta. 2014 Aug;1839(8):676-85. doi: 10.1016/j.bbagrm.2014.03.011. Epub 2014 Mar 28.
7
Multivalent nucleosome scaffolding by bromodomain and extraterminal domain tandem bromodomains.由溴结构域和额外末端结构域串联溴结构域介导的多价核小体支架作用
J Biol Chem. 2025 Mar;301(3):108289. doi: 10.1016/j.jbc.2025.108289. Epub 2025 Feb 10.
8
Bromodomains and their pharmacological inhibitors.溴结构域及其药理学抑制剂。
ChemMedChem. 2014 Mar;9(3):438-64. doi: 10.1002/cmdc.201300434. Epub 2014 Feb 4.
9
3,5-dimethylisoxazoles act as acetyl-lysine-mimetic bromodomain ligands.3,5-二甲基异恶唑类作为乙酰赖氨酸类似物溴结构域配体。
J Med Chem. 2011 Oct 13;54(19):6761-70. doi: 10.1021/jm200640v. Epub 2011 Sep 6.
10
Biochemical profiling of histone binding selectivity of the yeast bromodomain family.酵母溴结构域家族组蛋白结合选择性的生化特征分析。
PLoS One. 2010 Jan 26;5(1):e8903. doi: 10.1371/journal.pone.0008903.

引用本文的文献

1
A bottom-up approach to find lead compounds in expansive chemical spaces.一种在广阔化学空间中寻找先导化合物的自下而上方法。
Commun Chem. 2025 Aug 1;8(1):225. doi: 10.1038/s42004-025-01610-2.
2
Pioneering protein degradation for agricultural applications.用于农业应用的开创性蛋白质降解技术。
Commun Biol. 2025 Apr 9;8(1):591. doi: 10.1038/s42003-025-08013-y.
3
Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach.作为一种抗白血病方法,单一FLT3抑制剂与双重FLT3/TAF1抑制剂的开发与比较。
PLoS One. 2025 Mar 28;20(3):e0320443. doi: 10.1371/journal.pone.0320443. eCollection 2025.
4
An updated patent review of BRD4 degraders.BRD4 降解剂的最新专利审查
Expert Opin Ther Pat. 2024 Oct;34(10):929-951. doi: 10.1080/13543776.2024.2400166. Epub 2024 Sep 4.
5
Identification of novel bromodomain inhibitors of bromodomain factor 2 (BDF2) using a fluorescence polarization-based high-throughput assay.采用基于荧光偏振的高通量筛选方法鉴定新型溴结构域因子 2(BDF2)的溴结构域抑制剂。
Antimicrob Agents Chemother. 2024 Aug 7;68(8):e0024324. doi: 10.1128/aac.00243-24. Epub 2024 Jul 19.
6
Binding Mechanism of Inhibitors to BRD4 and BRD9 Decoded by Multiple Independent Molecular Dynamics Simulations and Deep Learning.通过多重独立分子动力学模拟和深度学习解析抑制剂与BRD4和BRD9的结合机制
Molecules. 2024 Apr 19;29(8):1857. doi: 10.3390/molecules29081857.
7
Small Molecule Ligands of the BET-like Bromodomain, BRD3, Affect Survival, Oviposition, and Development.小分子配体结合 BET 样溴结构域 BRD3 影响生存、产卵和发育。
J Med Chem. 2023 Dec 14;66(23):15801-15822. doi: 10.1021/acs.jmedchem.3c01321. Epub 2023 Dec 4.
8
Bromodomain Factor 5 as a Target for Antileishmanial Drug Discovery.溴结构域因子 5 作为抗利什曼原虫药物发现的靶标。
ACS Infect Dis. 2023 Nov 10;9(11):2340-2357. doi: 10.1021/acsinfecdis.3c00431. Epub 2023 Oct 31.
9
Mutate and Conjugate: A Method to Enable Rapid In-Cell Target Validation.突变与共轭:一种实现细胞内快速靶标验证的方法。
ACS Chem Biol. 2023 Nov 17;18(11):2405-2417. doi: 10.1021/acschembio.3c00437. Epub 2023 Oct 24.
10
Exploiting ELIOT for Scaffold-Repurposing Opportunities: TRIM33 a Possible Novel E3 Ligase to Expand the Toolbox for PROTAC Design.利用 ELIOT 寻找支架再利用机会:TRIM33 可能是一种新型 E3 连接酶,可扩展 PROTAC 设计工具包。
Int J Mol Sci. 2022 Nov 17;23(22):14218. doi: 10.3390/ijms232214218.